è¦ããã§ããå°±è·æ°·æ²³æä¸ä»£ãæ¯ããããã²ããããã親ã®é«é½¢åãå¿èº«ä¸èª¿ã®40ï¼50代â¦å®æ°é£æºã§æ¯æ´å å®
è¦ããã§ããå°±è·æ°·æ²³æä¸ä»£ãæ¯ããããã²ããããã親ã®é«é½¢åãå¿èº«ä¸èª¿ã®40ï¼50代â¦å®æ°é£æºã§æ¯æ´å å®
ã8æ5æ¥ AFPãç±³é£åå»è¬åå±ï¼US Food and Drug AdministrationãFDAï¼ã¯4æ¥ã3Dããªã³ã¿ã¼ã§è£½é ãããå»è¬åãåãã¦èªå¯ãããã¨ãçºè¡¨ããã ç±³ãªãã¤ãªï¼Ohioï¼å·ã«æ¬ç¤¾ãããå»è¬åã¡ã¼ã«ã¼ãã¢ãã¬ã·ã¢ã»ãã¡ã¼ãã¹ã¼ãã£ã«ã«ï¼Aprecia Pharmaceuticalsï¼ã¯ãèªç¤¾ã®3Dããªã³ã¿ã¼ã»ã·ã¹ãã ã§ã1é æ大1000ããªã°ã©ã ã¾ã§ã®è¬ã製é ã§ããã¨è¿°ã¹ã¦ããã AFPã®åæã«å¿ããå社ã«ããã¨ä»åã3Dããªã³ã¿ã¼ã§è£½é ãããè¬ã¨ãã¦åãã¦FDAã«èªå¯ãããã®ã¯ãã¹ããªã¿ã ï¼Spritamï¼ãã¨ãããã¦ãããæ²»çè¬ã®é å¤ãã浸éæ§ãé«ã製å¤ãã§ãããããªéã®æ¶²ä½ã§æº¶ãããããé å¤ã飲ã¿è¾¼ãã®ã«è¦å´ãã¦ãã人ãåã©ãã§ãæè¬ããããã¨ããã(c)AFP
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}